Search research articles
Contact Us
Filters
Showing results (31-40 of 92) with videos related to
Page
of 10
Sort By:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|
December 3, 2016
Tolerance and Efficacy with Simultaneous Use of Two Monoclonal Antibodies for a Patient with Hypereosinophilic Syndrome and Ulcerative Colitis
Bhavisha Patel, Joseph H Butterfield, Catherine R Weiler, et al.
Annals of Medicine
|
March 26, 2016
Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options
Lawrence B Afrin, Joseph H Butterfield, Martin Raithel, et al.
Leukemia Research
|
March 3, 2007
Global cytokine analysis in myeloproliferative disorders
Ching-Liang Ho, Terra L Lasho, Joseph H Butterfield, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 19, 2012
Systemic reactions to allergen immunotherapy: a role for measuring a PGD2 metabolite?
Matthew A Rank, Hirohito Kita, James T Li, et al.
Journal of Cutaneous Pathology
|
February 15, 2023
Clinical and histopathological features of hypereosinophilic syndrome with cutaneous involvement: The Mayo Clinic Experience
Jacqueline Zayas, Margot S Peters, Joseph H Butterfield, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 14, 2015
Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia
Benjamin L Wright, Joseph H Butterfield, Kristin M Leiferman, et al.
International Archives of Allergy and Immunology
|
February 18, 2025
Hereditary Alpha Tryptasemia: Survey of Concomitant Genetic Testing
Joseph H Butterfield, Arveen K Bhasin, Leah L Ishmael, et al.
The Journal of Allergy and Clinical Immunology
|
May 13, 2022
Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia
Matthew P Giannetti, Grace Godwin, Emily Weller, et al.
American Journal of Hematology
|
November 6, 2009
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
Ken H Lim, Animesh Pardanani, Joseph H Butterfield, et al.
Lancet (London, England)
|
June 6, 2002
Treatment of hypereosinophilic syndrome with imatinib mesilate
Gerald J Gleich, Kristin M Leiferman, Animesh Pardanani, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 92) with videos related to
Sort By:
Page
of 10
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|
December 3, 2016
Tolerance and Efficacy with Simultaneous Use of Two Monoclonal Antibodies for a Patient with Hypereosinophilic Syndrome and Ulcerative Colitis
Bhavisha Patel, Joseph H Butterfield, Catherine R Weiler, et al.
Annals of Medicine
|
March 26, 2016
Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options
Lawrence B Afrin, Joseph H Butterfield, Martin Raithel, et al.
Leukemia Research
|
March 3, 2007
Global cytokine analysis in myeloproliferative disorders
Ching-Liang Ho, Terra L Lasho, Joseph H Butterfield, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 19, 2012
Systemic reactions to allergen immunotherapy: a role for measuring a PGD2 metabolite?
Matthew A Rank, Hirohito Kita, James T Li, et al.
Journal of Cutaneous Pathology
|
February 15, 2023
Clinical and histopathological features of hypereosinophilic syndrome with cutaneous involvement: The Mayo Clinic Experience
Jacqueline Zayas, Margot S Peters, Joseph H Butterfield, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 14, 2015
Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia
Benjamin L Wright, Joseph H Butterfield, Kristin M Leiferman, et al.
International Archives of Allergy and Immunology
|
February 18, 2025
Hereditary Alpha Tryptasemia: Survey of Concomitant Genetic Testing
Joseph H Butterfield, Arveen K Bhasin, Leah L Ishmael, et al.
The Journal of Allergy and Clinical Immunology
|
May 13, 2022
Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia
Matthew P Giannetti, Grace Godwin, Emily Weller, et al.
American Journal of Hematology
|
November 6, 2009
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
Ken H Lim, Animesh Pardanani, Joseph H Butterfield, et al.
Lancet (London, England)
|
June 6, 2002
Treatment of hypereosinophilic syndrome with imatinib mesilate
Gerald J Gleich, Kristin M Leiferman, Animesh Pardanani, et al.
Page
of 10